6

KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Download PDF Report

Upload
vomien
View
217
Download
0

Embed Size (px)

Citation preview

Page 1: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 2: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 3: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 4: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 5: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 6: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Aerococcus urinae – A potent biofilm builder in endocarditis

Aerococcus urinae – A potent biofilm builder in endocarditis

Documents

C OVÁRIO INFLUÊNCIA DE POLIMORFISMOS NOS CYP3A4 E LIG4 ...€¦ · Cancro do Ovário: Influência de polimorfismos nos genes CYP3A4 e LIG4 na susceptibilidade e resposta farmacogenómica

C OVÁRIO INFLUÊNCIA DE POLIMORFISMOS NOS CYP3A4 E LIG4 ...€¦ · Cancro do Ovário: Influência de polimorfismos nos genes CYP3A4 e LIG4 na susceptibilidade e resposta farmacogenómica

Documents

ANEXA I REZUMATUL CARACTERISTICILOR PRODUSULUI · pasaj hepatic, mediată de enzima CYP3A4. Se recomandă precauţie la administrarea concomitentă cu inhibitori puternici ai CYP3A4

ANEXA I REZUMATUL CARACTERISTICILOR PRODUSULUI · pasaj hepatic, mediată de enzima CYP3A4. Se recomandă precauţie la administrarea concomitentă cu inhibitori puternici ai CYP3A4

Documents

36 Potent Foods To Help You Lose Weight

36 Potent Foods To Help You Lose Weight

Health & Medicine

Intermittent dosing of RMC-4630, a potent, selective

Intermittent dosing of RMC-4630, a potent, selective

Documents

Catechins and procyanidins of ginkgo biloba show potent

Catechins and procyanidins of ginkgo biloba show potent

Documents

ANEXA I REZUMATUL CARACTERISTICILOR … · Administrare concomitentă cu inductori puternici ai CYP3A4/5 precum rifampicină, ... CYP3A4 şi/sau ai CYP3A5 poate reduce concentraţiileplasmatice

ANEXA I REZUMATUL CARACTERISTICILOR … · Administrare concomitentă cu inductori puternici ai CYP3A4/5 precum rifampicină, ... CYP3A4 şi/sau ai CYP3A5 poate reduce concentraţiileplasmatice

Documents

Lucrare de Licenta Valorificarea Bazei Materiale Si a Potent

Lucrare de Licenta Valorificarea Bazei Materiale Si a Potent

Documents

BILAGI PRODUKTRESUME - European Medicines Agency · Glykæmisk kontrol skal nøje vurderes, når saxagliptin anvendes samtidig med en potent CYP3A4-inducer. Samtidig administration

BILAGI PRODUKTRESUME - European Medicines Agency · Glykæmisk kontrol skal nøje vurderes, når saxagliptin anvendes samtidig med en potent CYP3A4-inducer. Samtidig administration

Documents

Supporting Information Bioevaluation as Potent ... · S1 Supporting Information An Insight into Tetrahydro-β-carboline-Tetrazole Hybrids: Synthesis and Bioevaluation as Potent Antileishmanial

Supporting Information Bioevaluation as Potent ... · S1 Supporting Information An Insight into Tetrahydro-β-carboline-Tetrazole Hybrids: Synthesis and Bioevaluation as Potent Antileishmanial

Documents

Design and synthesis of colchicine derivatives with potent in ...S1 ELECTRONIC SUPPORTING INFORMATION (ESI) Design and synthesis of colchicine derivatives with potent in vitro and

Design and synthesis of colchicine derivatives with potent in ...S1 ELECTRONIC SUPPORTING INFORMATION (ESI) Design and synthesis of colchicine derivatives with potent in vitro and

Documents

Development of Potent and Selective Inhibitors of Aldo

Development of Potent and Selective Inhibitors of Aldo

Documents

Potent RCV ITIL Intermediate Study Material

Potent RCV ITIL Intermediate Study Material

Documents

ARTICLE Broad and potent neutralizing human antibodies to

ARTICLE Broad and potent neutralizing human antibodies to

Documents

FARMAKOVIGJILENCAomi.al/.../materialet-e-trajnimit-te-farmakovigjilences.docx · Web viewKonsiderohet si makrolidi me i sigurt per terapi sebashku me agjent qe bllokojne CYP3A4. CYP3A4

FARMAKOVIGJILENCAomi.al/.../materialet-e-trajnimit-te-farmakovigjilences.docx · Web viewKonsiderohet si makrolidi me i sigurt per terapi sebashku me agjent qe bllokojne CYP3A4. CYP3A4

Documents

CYP3A4 · 2020-07-15 · 폐경후질출혈 2019.05.07 cyp3a4 억제제: 트리암시놀론은 cyp3a4 기질이다. 케 토코나졸은 특정 코르티코스테로이드제의 대사를

CYP3A4 · 2020-07-15 · 폐경후질출혈 2019.05.07 cyp3a4 억제제: 트리암시놀론은 cyp3a4 기질이다. 케 토코나졸은 특정 코르티코스테로이드제의 대사를

Documents

Acid Hydrazides, Potent Reagents for Synthesis of Oxygen …szolcsanyi/education/files/Chemia... · 2014-08-21 · Acid Hydrazides, Potent Reagents for Synthesis of Oxygen‑, Nitrogen‑,

Acid Hydrazides, Potent Reagents for Synthesis of Oxygen …szolcsanyi/education/files/Chemia... · 2014-08-21 · Acid Hydrazides, Potent Reagents for Synthesis of Oxygen‑, Nitrogen‑,

Documents

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of … · Translational Cancer Mechanisms and Therapy Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of … · Translational Cancer Mechanisms and Therapy Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor

Documents

Facile green synthesis and potent antimicrobial efﬁcacy of

Facile green synthesis and potent antimicrobial efﬁcacy of

Documents

Ghid clinic de tratament substitutiv al dependenței de opiacee · CYP2C19, CYP3A4) sau în tubul digestiv (CYP3A4). Există o mare variabilitate individuală a conținutului în

Ghid clinic de tratament substitutiv al dependenței de opiacee · CYP2C19, CYP3A4) sau în tubul digestiv (CYP3A4). Există o mare variabilitate individuală a conținutului în

Documents

PENGARUH POLIMORFISME GEN CYP3A4 DAN DURASI … · 2019. 1. 12. · Tujuan penelitian ini adalah untuk mengetahui pengaruh polimorfisme gen CYP3A4 dan durasi pemakaian simvastatin

PENGARUH POLIMORFISME GEN CYP3A4 DAN DURASI … · 2019. 1. 12. · Tujuan penelitian ini adalah untuk mengetahui pengaruh polimorfisme gen CYP3A4 dan durasi pemakaian simvastatin

Documents

Rappresentazione del CITOCROMO CYP3A4, …...Rappresentazione del CITOCROMO CYP3A4, l'enzima maggior-mente coinvolto nella degradazione dei farmaci e nelle Interazio-ni farmacologiche

Rappresentazione del CITOCROMO CYP3A4, …...Rappresentazione del CITOCROMO CYP3A4, l'enzima maggior-mente coinvolto nella degradazione dei farmaci e nelle Interazio-ni farmacologiche

Documents

PRILOG I. - European Medicines Agency · CYP3A4/5 i P-glikoproteina) ili nakon 6 dana flukonazola 200 mg/dan (inhibitor CYP2C9, CYP2C19 i CYP3A4/5) u zdravih ispitanika, opaženo

PRILOG I. - European Medicines Agency · CYP3A4/5 i P-glikoproteina) ili nakon 6 dana flukonazola 200 mg/dan (inhibitor CYP2C9, CYP2C19 i CYP3A4/5) u zdravih ispitanika, opaženo

Documents

13 most potent fermented foods for a healthy bellybetterbellyproject.com/assets/files/13_most_potent...13 Most Potent Fermented Foods for a Healthy belly by Summer Bock Introduction

13 most potent fermented foods for a healthy bellybetterbellyproject.com/assets/files/13_most_potent...13 Most Potent Fermented Foods for a Healthy belly by Summer Bock Introduction

Documents

€¦ · 50 1% 55-370b IJ7jY5P CYP3A4 CYP3A4 CtlBD 1) 1) (D 95370b cnB CYP3A4 ct1BD æn-so 22)

€¦ · 50 1% 55-370b IJ7jY5P CYP3A4 CYP3A4 CtlBD 1) 1) (D 95370b cnB CYP3A4 ct1BD æn-so 22)

Documents

1. BEùERİ TIBBİ ÜRÜNÜN ADI - pdf.ilacprospektusu.com · Saksagliptinin potent CYP3A4/5 indükleyicisi rifampisin ile birlikte uygulanması, saksagliptinin C maks ve EAA değerlerini

1. BEùERİ TIBBİ ÜRÜNÜN ADI - pdf.ilacprospektusu.com · Saksagliptinin potent CYP3A4/5 indükleyicisi rifampisin ile birlikte uygulanması, saksagliptinin C maks ve EAA değerlerini

Documents

Research Article Suxiao Jiuxin Pill Induces Potent Relaxation ...Research Article Suxiao Jiuxin Pill Induces Potent Relaxation and Inhibition on Contraction in Human Artery and the

Research Article Suxiao Jiuxin Pill Induces Potent Relaxation ...Research Article Suxiao Jiuxin Pill Induces Potent Relaxation and Inhibition on Contraction in Human Artery and the

Documents

BILAGI PRODUKTRESUME - European Commission · Glykæmisk kontrol skal nøje vurderes, når saxagliptin anvendes samtidig med en potent CYP3A4-inducer. Samtidig administration af saxagliptin

BILAGI PRODUKTRESUME - European Commission · Glykæmisk kontrol skal nøje vurderes, når saxagliptin anvendes samtidig med en potent CYP3A4-inducer. Samtidig administration af saxagliptin

Documents

Dithiocarbamates as Potent Inhibitors of Nuclear Factor KB

Dithiocarbamates as Potent Inhibitors of Nuclear Factor KB

Documents

Highly potent and selective acylguanidine- type histamine H2

Highly potent and selective acylguanidine- type histamine H2

Documents